Search

Your search keyword '"Möbs, Markus"' showing total 183 results
Start Over Author "Möbs, Markus"
183 results on '"Möbs, Markus"'

1. Benchmarking whole exome sequencing in the German network for personalized medicine

Author

Menzel, Michael, Martis-Thiele, Mihaela, Goldschmid, Hannah, Ott, Alexander, Romanovsky, Eva, Siemanowski-Hrach, Janna, Seillier, Lancelot, Brüchle, Nadina Ortiz, Maurer, Angela, Lehmann, Kjong-Van, Begemann, Matthias, Elbracht, Miriam, Meyer, Robert, Dintner, Sebastian, Claus, Rainer, Meier-Kolthoff, Jan P., Blanc, Eric, Möbs, Markus, Joosten, Maria, Benary, Manuela, Basitta, Patrick, Hölscher, Florian, Tischler, Verena, Groß, Thomas, Kutz, Oliver, Prause, Rebecca, William, Doreen, Horny, Kai, Goering, Wolfgang, Sivalingam, Sugirthan, Borkhardt, Arndt, Blank, Cornelia, Junk, Stefanie V., Yasin, Layal, Moskalev, Evgeny A., Carta, Maria Giulia, Ferrazzi, Fulvia, Tögel, Lars, Wolter, Steffen, Adam, Eugen, Matysiak, Uta, Rosenthal, Tessa, Dönitz, Jürgen, Lehmann, Ulrich, Schmidt, Gunnar, Bartels, Stephan, Hofmann, Winfried, Hirsch, Steffen, Dikow, Nicola, Göbel, Kirsten, Banan, Rouzbeh, Hamelmann, Stefan, Fink, Annette, Ball, Markus, Neumann, Olaf, Rehker, Jan, Kloth, Michael, Murtagh, Justin, Hartmann, Nils, Jurmeister, Phillip, Mock, Andreas, Kumbrink, Jörg, Jung, Andreas, Mayr, Eva-Maria, Jacob, Anne, Trautmann, Marcel, Kirmse, Santina, Falkenberg, Kim, Ruckert, Christian, Hirsch, Daniela, Immel, Alexander, Dietmaier, Wolfgang, Haack, Tobias, Marienfeld, Ralf, Fürstberger, Axel, Niewöhner, Jakob, Gerstenmaier, Uwe, Eberhardt, Timo, Greif, Philipp A., Appenzeller, Silke, Maurus, Katja, Doll, Julia, Jelting, Yvonne, Jonigk, Danny, Märkl, Bruno, Beule, Dieter, Horst, David, Wulf, Anna-Lena, Aust, Daniela, Werner, Martin, Reuter-Jessen, Kirsten, Ströbel, Philipp, Auber, Bernd, Sahm, Felix, Merkelbach-Bruse, Sabine, Siebolts, Udo, Roth, Wilfried, Lassmann, Silke, Klauschen, Frederick, Gaisa, Nadine T., Weichert, Wilko, Evert, Matthias, Armeanu-Ebinger, Sorin, Ossowski, Stephan, Schroeder, Christopher, Schaaf, Christian P., Malek, Nisar, Schirmacher, Peter, Kazdal, Daniel, Pfarr, Nicole, Budczies, Jan, and Stenzinger, Albrecht

Published
2024
Full Text
View/download PDF

3. Decoding molecular programs in melanoma brain metastases

Author

Radke, Josefine, Schumann, Elisa, Onken, Julia, Koll, Randi, Acker, Güliz, Bodnar, Bohdan, Senger, Carolin, Tierling, Sascha, Möbs, Markus, Vajkoczy, Peter, Vidal, Anna, Högler, Sandra, Kodajova, Petra, Westphal, Dana, Meier, Friedegund, Heppner, Frank, Kreuzer-Redmer, Susanne, Grebien, Florian, Jürchott, Karsten, and Redmer, Torben

Published
2022
Full Text
View/download PDF

4. A diagnostic challenge of KIT p.V559D and BRAF p.G469A mutations in a paragastric mass.

Author

Habringer, Stefan, Ihlow, Jana, Kleo, Karsten, Klostermann, Anna, Schmidt, Max, Chai, Lidan, Knödler, Maren, Leyvraz, Serge, Sigler, Christian, Sinn, Bruno, Maschmeyer, Georg, Jegodka, Yvette, Benary, Manuela, Ott, Claus-Eric, Tinhofer, Ingeborg, Schäfer, Reinhold, Möbs, Markus, Keller, Ulrich, Keilholz, Ulrich, and Rieke, Damian T

Subjects
THERAPEUTIC use of antineoplastic agents, GASTROINTESTINAL tumors, CANCER invasiveness, DIFFERENTIAL diagnosis, COMPUTED tomography, TREATMENT effectiveness, TRANSFERASES, GENETIC mutation, GENETIC testing, GENOTYPES
Abstract

A patient with gastrointestinal stroma tumor (GIST) and KIT p.V559D and BRAF p.G469A alterations was referred to our institutional molecular tumor board (MTB) to discuss therapeutic implications. The patient had been diagnosed with B-cell chronic lymphocytic leukemia (CLL) years prior to the MTB presentation. GIST had been diagnosed 1 month earlier. After structured clinical annotation of the molecular alterations and interdisciplinary discussion, we considered BRAF/KIT co-mutation unlikely in a treatment-naïve GIST. Discordant variant allele frequencies furthermore suggested a second malignancy. NGS of a CLL sample revealed the identical class 2 BRAF alteration, thus supporting admixture of CLL cells in the paragastric mass, leading to the detection of 2 alterations. Following the MTB recommendation, the patient received imatinib and had a radiographic response. Structured annotation and interdisciplinary discussion in specialized tumor boards facilitate the clinical management of complex molecular findings. Coexisting malignancies and clonal hematopoiesis warrant consideration in case of complex and uncommon molecular findings. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

6. EuroClonality-NGS Recommendations for Evaluation of B-Cell Clonality Analysis by Next-Generation Sequencing

Author

van den Brand, Michiel, primary, Möbs, Markus, additional, Otto, Franziska, additional, Kroeze, Leonie I., additional, Gonzalez de Castro, David, additional, Stamatopoulos, Kostas, additional, Davi, Frederic, additional, Bravetti, Clotilde, additional, Kolijn, P. Martijn, additional, Vlachonikola, Elisavet, additional, Stewart, J. Peter, additional, Pott, Christiane, additional, Hummel, Michael, additional, Darzentas, Nikos, additional, Langerak, Anton W., additional, Fend, Falko, additional, and Groenen, Patricia J.T.A., additional

Published
2023
Full Text
View/download PDF

7. Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS

Author

Scheijen, Blanca, Meijers, Ruud W. J., Rijntjes, Jos, van der Klift, Michèle Y., Möbs, Markus, Steinhilber, Julia, Reigl, Tomas, van den Brand, Michiel, Kotrová, Michaela, Ritter, Julia-Marie, Catherwood, Mark A., Stamatopoulos, Kostas, Brüggemann, Monika, Davi, Frédéric, Darzentas, Nikos, Pott, Christiane, Fend, Falko, Hummel, Michael, Langerak, Anton W., Groenen, Patricia J. T. A., and on behalf of the EuroClonality-NGS Working Group

Published
2019
Full Text
View/download PDF

10. Figure S3 from Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model

Author

Benten, Daniel, primary, Behrang, Yasmin, primary, Unrau, Ludmilla, primary, Weissmann, Victoria, primary, Wolters-Eisfeld, Gerrit, primary, Burdak-Rothkamm, Susanne, primary, Stahl, Felix R., primary, Anlauf, Martin, primary, Grabowski, Patricia, primary, Möbs, Markus, primary, Dieckhoff, Jan, primary, Sipos, Bence, primary, Fahl, Martina, primary, Eggers, Corinna, primary, Perez, Daniel, primary, Bockhorn, Maximillian, primary, Izbicki, Jakob R., primary, Lohse, Ansgar W., primary, and Schrader, Jörg, primary

Published
2023
Full Text
View/download PDF

12. Data from Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model

Author

Benten, Daniel, primary, Behrang, Yasmin, primary, Unrau, Ludmilla, primary, Weissmann, Victoria, primary, Wolters-Eisfeld, Gerrit, primary, Burdak-Rothkamm, Susanne, primary, Stahl, Felix R., primary, Anlauf, Martin, primary, Grabowski, Patricia, primary, Möbs, Markus, primary, Dieckhoff, Jan, primary, Sipos, Bence, primary, Fahl, Martina, primary, Eggers, Corinna, primary, Perez, Daniel, primary, Bockhorn, Maximillian, primary, Izbicki, Jakob R., primary, Lohse, Ansgar W., primary, and Schrader, Jörg, primary

Published
2023
Full Text
View/download PDF

14. Supplementary Figure 1 from IL32 Is Progressively Expressed in Mycosis Fungoides Independent of Helper T-cell 2 and Helper T-cell 9 Polarization

Author

Ohmatsu, Hanako, primary, Humme, Daniel, primary, Gulati, Nicholas, primary, Gonzalez, Juana, primary, Möbs, Markus, primary, Suárez-Fariñas, Mayte, primary, Cardinale, Irma, primary, Mitsui, Hiroshi, primary, Guttman-Yassky, Emma, primary, Sterry, Wolfram, primary, and Krueger, James G., primary

Published
2023
Full Text
View/download PDF

17. Supplementary Figure Legend from IL32 Is Progressively Expressed in Mycosis Fungoides Independent of Helper T-cell 2 and Helper T-cell 9 Polarization

Author

Ohmatsu, Hanako, primary, Humme, Daniel, primary, Gulati, Nicholas, primary, Gonzalez, Juana, primary, Möbs, Markus, primary, Suárez-Fariñas, Mayte, primary, Cardinale, Irma, primary, Mitsui, Hiroshi, primary, Guttman-Yassky, Emma, primary, Sterry, Wolfram, primary, and Krueger, James G., primary

Published
2023
Full Text
View/download PDF

18. Supplementary Methods from Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model

Author

Benten, Daniel, primary, Behrang, Yasmin, primary, Unrau, Ludmilla, primary, Weissmann, Victoria, primary, Wolters-Eisfeld, Gerrit, primary, Burdak-Rothkamm, Susanne, primary, Stahl, Felix R., primary, Anlauf, Martin, primary, Grabowski, Patricia, primary, Möbs, Markus, primary, Dieckhoff, Jan, primary, Sipos, Bence, primary, Fahl, Martina, primary, Eggers, Corinna, primary, Perez, Daniel, primary, Bockhorn, Maximillian, primary, Izbicki, Jakob R., primary, Lohse, Ansgar W., primary, and Schrader, Jörg, primary

Published
2023
Full Text
View/download PDF

19. Supplementary Data revised from Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial

Author

Loibl, Sibylle, primary, Treue, Denise, primary, Budczies, Jan, primary, Weber, Karsten, primary, Stenzinger, Albrecht, primary, Schmitt, Wolfgang D., primary, Weichert, Wilko, primary, Jank, Paul, primary, Furlanetto, Jenny, primary, Klauschen, Frederick, primary, Karn, Thomas, primary, Pfarr, Nicole, primary, von Minckwitz, Gunter, primary, Möbs, Markus, primary, Jackisch, Christian, primary, Sers, Christine, primary, Schneeweiss, Andreas, primary, Fasching, Peter A., primary, Schem, Christian, primary, Hummel, Michael, primary, van Mackelenbergh, Marion, primary, Nekljudova, Valentina, primary, Untch, Michael, primary, and Denkert, Carsten, primary

Published
2023
Full Text
View/download PDF

20. EuroClonality-NGS Recommendations for Evaluation of B-Cell Clonality Analysis by Next-Generation Sequencing:A Structured Approach with the DEPART Algorithm

Author

van den Brand, Michiel, Möbs, Markus, Otto, Franziska, Kroeze, Leonie I, Castro, David Gonzalez-de, Stamatopoulos, Kostas, Davi, Frederic, Bravetti, Clotilde, Kolijn, P Martijn, Vlachonikola, Elisavet, Stewart, J Peter, Pott, Christiane, Hummel, Michael, Darzentas, Nikos, Langerak, Anton W, Fend, Falko, Groenen, Patricia J T A, van den Brand, Michiel, Möbs, Markus, Otto, Franziska, Kroeze, Leonie I, Castro, David Gonzalez-de, Stamatopoulos, Kostas, Davi, Frederic, Bravetti, Clotilde, Kolijn, P Martijn, Vlachonikola, Elisavet, Stewart, J Peter, Pott, Christiane, Hummel, Michael, Darzentas, Nikos, Langerak, Anton W, Fend, Falko, and Groenen, Patricia J T A

Abstract

Next-generation sequencing (NGS)-based clonality analysis allows in-depth assessment of the clonal composition of a sample with high sensitivity for detecting small clones. Within the EuroClonality–NGS Working Group, a protocol for NGS Ig clonality analysis was developed and validated previously. This NGS-based approach was designed to generate small amplicons, making it suitable for samples with suboptimal DNA quality, especially material derived from formalin-fixed, paraffin-embedded tissue. Using expert assessment of NGS Ig clonality results as a reference, a structured algorithmic approach to the assessment of NGS-amplicon–based B-cell clonality analysis was developed. A structured approach with the Detection of clonality through Evaluation of sample quality and assessment of Pattern, Abundance and RaTio (DEPART) algorithm was proposed, which consecutively evaluates sample quality, the pattern of the clonotypes present, the abundance of the most dominant clonotypes, and the ratio between the dominant clonotypes and the background to evaluate the different Ig gene targets. Specific issues with respect to evaluation of the various Ig targets as well as the integration of results of individual targets into a molecular clonality conclusion are discussed and illustrated with case examples. Finally, the importance of interpretation of NGS-based clonality results in clinical and histopathologic contexts is discussed. It is expected that these recommendations will have clinical utility to facilitate proper evaluation of clonality assessment.

Published
2023

22. NGS-based BRCA1/2 mutation testing of high-grade serous ovarian cancer tissue: results and conclusions of the first international round robin trial

Author

Endris, Volker, Stenzinger, Albrecht, Pfarr, Nicole, Penzel, Roland, Möbs, Markus, Lenze, Dido, Darb-Esfahani, Silvia, Hummel, Michael, Sabine-Merkelbach-Bruse, Jung, Andreas, Lehmann, Ulrich, Kreipe, Hans, Kirchner, Thomas, Büttner, Reinhard, Jochum, Wolfram, Höfler, Gerald, Dietel, Manfred, Weichert, Wilko, and Schirmacher, Peter

Published
2016
Full Text
View/download PDF

24. Decoding molecular programs in melanoma brain metastases

Author

Radke, Josefine, primary, Schumann, Elisa, additional, Onken, Julia, additional, Koll, Randi, additional, Acker, Güliz, additional, Bodnar, Bohdan, additional, Senger, Carolin, additional, Tierling, Sascha, additional, Möbs, Markus, additional, Vajkoczy, Peter, additional, Vidal, Anna, additional, Högler, Sandra, additional, Kodajova, Petra, additional, Westphal, Dana, additional, Meier, Friedegund, additional, Heppner, Frank, additional, Kreuzer-Redmer, Susanne, additional, Grebien, Florian, additional, Jürchott, Karsten, additional, and Redmer, Torben, additional

Published
2022
Full Text
View/download PDF

27. Next-Generation Sequencing–Based Clonality Assessment of Ig Gene Rearrangements

Author

van den Brand, Michiel, primary, Rijntjes, Jos, additional, Möbs, Markus, additional, Steinhilber, Julia, additional, van der Klift, Michèle Y., additional, Heezen, Kim C., additional, Kroeze, Leonie I., additional, Reigl, Tomas, additional, Porc, Jakub, additional, Darzentas, Nikos, additional, Luijks, Jeroen A.C.W., additional, Scheijen, Blanca, additional, Davi, Frédéric, additional, ElDaly, Hesham, additional, Liu, Hongxiang, additional, Anagnostopoulos, Ioannis, additional, Hummel, Michael, additional, Fend, Falko, additional, Langerak, Anton W., additional, and Groenen, Patricia J.T.A., additional

Published
2021
Full Text
View/download PDF

39. Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial

Author

Loibl, Sibylle, primary, Treue, Denise, additional, Budczies, Jan, additional, Weber, Karsten, additional, Stenzinger, Albrecht, additional, Schmitt, Wolfgang D., additional, Weichert, Wilko, additional, Jank, Paul, additional, Furlanetto, Jenny, additional, Klauschen, Frederick, additional, Karn, Thomas, additional, Pfarr, Nicole, additional, von Minckwitz, Gunter, additional, Möbs, Markus, additional, Jackisch, Christian, additional, Sers, Christine, additional, Schneeweiss, Andreas, additional, Fasching, Peter A., additional, Schem, Christian, additional, Hummel, Michael, additional, van Mackelenbergh, Marion, additional, Nekljudova, Valentina, additional, Untch, Michael, additional, and Denkert, Carsten, additional

Published
2019
Full Text
View/download PDF

40. The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models

Author

Nölting, Svenja, Rentsch, Jakob, Freitag, Helma, Detjen, Katharina, Briest, Franziska, Möbs, Markus, Weissmann, Victoria, Siegmund, Britta, Auernhammer, Christoph J, Aristizabal Prada, Elke Tatjana, Lauseker, Michael, Grossman, Ashley, Exner, Samantha, Fischer, Christian, Grötzinger, Carsten, Schrader, Jörg, Grabowski, Patricia, University of Zurich, and Grabowski, Patricia

Subjects
1000 Multidisciplinary, 10265 Clinic for Endocrinology and Diabetology, 610 Medicine & health
Published
2017

41. Genome-Wide Analysis of Interchromosomal Interaction Probabilities Reveals Chained Translocations and Overrepresentation of Translocation Breakpoints in Genes in a Cutaneous T-Cell Lymphoma Cell Line

Author

Steininger, Anne, primary, Ebert, Grit, additional, Becker, Benjamin V., additional, Assaf, Chalid, additional, Möbs, Markus, additional, Schmidt, Christian A., additional, Grabarczyk, Piotr, additional, Jensen, Lars R., additional, Przybylski, Grzegorz K., additional, Port, Matthias, additional, Kuss, Andreas W., additional, and Ullmann, Reinhard, additional

Published
2018
Full Text
View/download PDF

42. Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model

Author

Benten, Daniel, primary, Behrang, Yasmin, additional, Unrau, Ludmilla, additional, Weissmann, Victoria, additional, Wolters-Eisfeld, Gerrit, additional, Burdak-Rothkamm, Susanne, additional, Stahl, Felix R., additional, Anlauf, Martin, additional, Grabowski, Patricia, additional, Möbs, Markus, additional, Dieckhoff, Jan, additional, Sipos, Bence, additional, Fahl, Martina, additional, Eggers, Corinna, additional, Perez, Daniel, additional, Bockhorn, Maximillian, additional, Izbicki, Jakob R., additional, Lohse, Ansgar W., additional, and Schrader, Jörg, additional

Published
2018
Full Text
View/download PDF

43. Mechanisms of Targeting the MDM2-p53-FOXM1 Axis in Well-Differentiated Intestinal Neuroendocrine Tumors

Author

Briest, Franziska, Grass, Irina, Sedding, Dagmar, Möbs, Markus, Christen, Friederike, Benecke, Joana, Fuchs, Karolin, Mende, Stefanie, Kaemmerer, Daniel, Sänger, Jörg, Kunze, Almut, Geisler, Christina, Freitag, Helma, Lewens, Florentine, Worpenberg, Lina, Iwaszkiewicz, Sara, Siegmund, Britta, Walther, Wolfgang, Hummel, Michael, Grabowski, Patricia, Briest, Franziska, Grass, Irina, Sedding, Dagmar, Möbs, Markus, Christen, Friederike, Benecke, Joana, Fuchs, Karolin, Mende, Stefanie, Kaemmerer, Daniel, Sänger, Jörg, Kunze, Almut, Geisler, Christina, Freitag, Helma, Lewens, Florentine, Worpenberg, Lina, Iwaszkiewicz, Sara, Siegmund, Britta, Walther, Wolfgang, Hummel, Michael, and Grabowski, Patricia

Abstract

Background/Aims: The tumor suppressor p53 is rarely mutated in gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) but they frequently show a strong expression of negative regulators of p53, rendering these tumors excellent targets for a p53 recovery therapy. Therefore, we analyzed the mechanisms of a p53 recovery therapy on intestinal neuroendocrine tumors in vitro and in vivo.Methods: By Western blot and immunohistochemistry, we found that in GEP-NEN biopsy material overexpression of MDM2 was present in intestinal NEN. Therefore, we analyzed the effect of a small-molecule inhibitor, nutlin-3a, in p53 wild-type and mutant GEP-NEN cell lines by proliferation assay, flow cytometry, immunofluorescence, Western blot, and by multiplex gene expression analysis. Finally, we analyzed the antitumor effect of nutlin-3a in a xenograft mouse model in vivo. During the study, the tumor volume was determined. Results: The midgut wild-type cell line KRJ-I responded to the treatment with cell cycle arrest and apoptosis. By gene expression analysis, we could demonstrate that nutlins reactivated an antiproliferative p53 response. KRJ-I-derived xenograft tumors showed a significantly decreased tumor growth upon treatment with nutlin-3a in vivo. Furthermore, our data suggest that MDM2 also influences the expression of the oncogene FOXM1 in a p53-independent manner. Subsequently, a combined treatment of nutlin-3a and cisplatin (as chemoresistance model) resulted in synergistically enhanced antiproliferative effects. Conclusion: In summary, MDM2 overexpression is a frequent event in p53 wild-type intestinal neuroendocrine neoplasms and therefore recovery of a p53 response might be a novel personalized treatment approach in these tumors., Peer Reviewed

Published
2017

44. Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer

Author

Taromi, Sanaz, primary, Lewens, Florentine, additional, Arsenic, Ruza, additional, Sedding, Dagmar, additional, Sänger, Jörg, additional, Kunze, Almut, additional, Möbs, Markus, additional, Benecke, Joana, additional, Freitag, Helma, additional, Christen, Friederike, additional, Kaemmerer, Daniel, additional, Lupp, Amelie, additional, Heilmann, Mareike, additional, Lammert, Hedwig, additional, Schneider, Claus-Peter, additional, Richter, Karen, additional, Hummel, Michael, additional, Siegmund, Britta, additional, Burger, Meike, additional, Briest, Franziska, additional, and Grabowski, Patricia, additional

Published
2017
Full Text
View/download PDF

45. Mechanisms of Targeting the MDM2-p53-FOXM1 Axis in Well-Differentiated Intestinal Neuroendocrine Tumors

Author

Briest, Franziska, primary, Grass, Irina, additional, Sedding, Dagmar, additional, Möbs, Markus, additional, Christen, Friederike, additional, Benecke, Joana, additional, Fuchs, Karolin, additional, Mende, Stefanie, additional, Kaemmerer, Daniel, additional, Sänger, Jörg, additional, Kunze, Almut, additional, Geisler, Christina, additional, Freitag, Helma, additional, Lewens, Florentine, additional, Worpenberg, Lina, additional, Iwaszkiewicz, Sara, additional, Siegmund, Britta, additional, Walther, Wolfgang, additional, Hummel, Michael, additional, and Grabowski, Patricia, additional

Published
2017
Full Text
View/download PDF

47. DNA copy number changes define spatial patterns of heterogeneity in colorectal cancer

Author

Mamlouk, Soulafa, primary, Childs, Liam Harold, additional, Aust, Daniela, additional, Heim, Daniel, additional, Melching, Friederike, additional, Oliveira, Cristiano, additional, Wolf, Thomas, additional, Durek, Pawel, additional, Schumacher, Dirk, additional, Bläker, Hendrik, additional, von Winterfeld, Moritz, additional, Gastl, Bastian, additional, Möhr, Kerstin, additional, Menne, Andrea, additional, Zeugner, Silke, additional, Redmer, Torben, additional, Lenze, Dido, additional, Tierling, Sascha, additional, Möbs, Markus, additional, Weichert, Wilko, additional, Folprecht, Gunnar, additional, Blanc, Eric, additional, Beule, Dieter, additional, Schäfer, Reinhold, additional, Morkel, Markus, additional, Klauschen, Frederick, additional, Leser, Ulf, additional, and Sers, Christine, additional

Published
2017
Full Text
View/download PDF

48. Inactivation of RUNX3/p46 Promotes Cutaneous T-Cell Lymphoma

Author

Haider, Ahmed, primary, Steininger, Anne, additional, Ullmann, Reinhard, additional, Hummel, Michael, additional, Dimitrova, Lora, additional, Beyer, Marc, additional, Vandersee, Staffan, additional, Lenze, Dido, additional, Sterry, Wolfram, additional, Assaf, Chalid, additional, and Möbs, Markus, additional

Published
2016
Full Text
View/download PDF

49. Role ofTP53mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy

Author

Darb-Esfahani, Silvia, primary, Denkert, Carsten, additional, Stenzinger, Albrecht, additional, Salat, Christoph, additional, Sinn, Bruno, additional, Schem, Christian, additional, Endris, Volker, additional, Klare, Peter, additional, Schmitt, Wolfgang, additional, Blohmer, Jens-Uwe, additional, Weichert, Wilko, additional, Möbs, Markus, additional, Tesch, Hans, additional, Kümmel, Sherko, additional, Sinn, Peter, additional, Jackisch, Christian, additional, Dietel, Manfred, additional, Reimer, Toralf, additional, Loi, Sherene, additional, Untch, Michael, additional, von Minckwitz, Gunter, additional, Nekljudova, Valentina, additional, and Loibl, Sibylle, additional

Published
2016
Full Text
View/download PDF

50. Multicenter Evaluation of a Novel Automated Rapid Detection System of BRAF Status in Formalin-Fixed, Paraffin-Embedded Tissues

Author

Schiefer, Ana-Iris, primary, Parlow, Laura, additional, Gabler, Lisa, additional, Mesteri, Ildiko, additional, Koperek, Oskar, additional, von Deimling, Andreas, additional, Streubel, Berthold, additional, Preusser, Matthias, additional, Lehmann, Annika, additional, Kellner, Udo, additional, Pauwels, Patrick, additional, Lambin, Suzan, additional, Dietel, Manfred, additional, Hummel, Michael, additional, Klauschen, Frederick, additional, Birner, Peter, additional, and Möbs, Markus, additional

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results